Vaccination
Research News and Information

Saturday, November 21, 2009

Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.

29 Nov 2009 OBJECTIVE: Loss of immunity to previous vaccination and timing of re-vaccination in children receiving chemotherapy remains controversial. The aim of this study was to investigate the immunity to vaccine preventable diseases in children with acute ... Read more...

Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface.

13 Nov 2009 BACKGROUND: Streptococcus suis serotype 2 (SS2) has evolved into a highly infectious entity, posing a great threat to public health. Screening for and identification of protective antigens plays an important role in developing therapies against SS2 ... Read more...

Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.

11 Nov 2009 Since first reports in April 2009, the 2009 pandemic influenza A (H1N1) virus has spread around the world. The pandemic virus is antigenically distinct from seasonal influenza A (H1N1) viruses targeted by seasonal influenza vaccines. Results from ... Read more...

Latest indexed articles for 'Vaccination'

These are the very latest articles for this heading:

• Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. 29 Nov 2009
• Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface. 13 Nov 2009
• Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. 11 Nov 2009
• Validation of neonatal tetanus elimination in the Congo by a lot quality-assurance cluster sample survey. 7 Nov 2009
• Has routine immunisation in Africa become endangered? 30 Oct 2009
• Sentinel hospital surveillance for rotavirus in latin american and Caribbean countries. 30 Oct 2009
• Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. 30 Oct 2009
• Global mortality associated with rotavirus disease among children in 2004. 30 Oct 2009
• How much could rotavirus vaccines reduce diarrhea-associated mortality in northern Ghana? A model to assess impact. 30 Oct 2009
• Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. 30 Oct 2009
• Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation. 30 Oct 2009
• A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. 30 Oct 2009
• Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015. 30 Oct 2009
• Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. 30 Oct 2009
• Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. 30 Oct 2009
• Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan. 30 Oct 2009
• Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. 30 Oct 2009
• Cost-effectiveness of rotavirus vaccination in peru. 30 Oct 2009
• Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. 30 Oct 2009
• Pathogenesis, treatment, and prevention of pneumococcal pneumonia. 29 Oct 2009

See a longer list of these articles.

Technical information about 'Vaccination'

Definition: Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.

Descriptor UI: D014611

Alternative terms: Vaccination; Vaccinations; Immunization, Active; Active Immunization; Active Immunizations; Immunizations, Active;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics; legislation & jurisprudence;

Tree Number: E02.095.520.400.530.890; E05.478.550.600.890; N02.421.726.758.310.890; N06.850.780.200.425.900; N06.850.780.680.310.890;

Technical Notes: do not use /util except by MeSH definition; Manual 26.22.2.2+; for prev only: coord IM with dis /prev (IM); for ther, index under IMMUNOTHERAPY or specific vaccine /ther use